Loading…
Legume seed containing furostanolic saponins studied for modest increases in free testosterone and libido in men; used traditionally to support lactation and post-meal blood glucose control.
Insulin resistance, pre-diabetes, type 2 diabetes, and metabolic syndrome.
Also known as: Trigonella foenum-graecum
Every published result for this pair, extracted and audited.
These charts group published studies by what they reported and how they were run — green marks studies that reported a benefit for this pairing. Tiers run from pooled analyses of many trials (strongest) to one-off observational reports.
Direction of reported outcomes for Fenugreek in blood sugar control.
Study designs behind these findings.
Outcomes reported as percentage changes for Fenugreek. Other units sit in the table above.
Every measured outcome, one row per finding - numbers exactly as reported.
| Study | Design | n | Duration | Outcome measured | Reported result | Direction |
|---|---|---|---|---|---|---|
| PMID 37451111 2023 | Systematic review | 3130 | - | fasting blood glucose (FBG) | -28.99 SMD (p < 0.05) | Benefit |
| PMID 37451111 2023 | Systematic review | 3130 | - | fasting blood glucose (FBG) | -9.73 SMD (p < 0.05) | Benefit |
| PMID 37451111 2023 | Systematic review | 3130 | - | fasting blood glucose (FBG) | -13.15 SMD (p < 0.05) | Benefit |
| PMID 37451111 2023 | Systematic review | 3130 | - | fasting blood glucose (FBG) | -19.64 SMD (p < 0.05) | Benefit |
| PMID 37451111 2023 | Systematic review | 3130 | - | HbA1C | -2.10 SMD | Benefit |
| PMID 37451111 2023 | Systematic review | 3130 | - | HbA1C | 0.84 SMD | Benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | 2 h plasma glucose during OGTT (2-hPG) | reported qualitatively | Benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Body mass index (BMI) | reported qualitatively | No benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Fasting blood glucose (FBG) | reported qualitatively | Benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Glycosylated hemoglobin (HbA1c) | reported qualitatively | Benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | High density lipoprotein (HDL-C) | reported qualitatively | Benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Homeostatic model assessment for insulin resistance (HOMA-IR) | reported qualitatively | No benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Low density lipoprotein (LDL-C) | reported qualitatively | No benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Total cholesterol (TC) | reported qualitatively | Benefit |
| PMID 37762302 2023 | Systematic review | 706 | - | Triglyceride (TG) | reported qualitatively | Benefit |
| PMID 22071637 2011 | Systematic review | - | - | Glycemic control (best evidence among Iranian antidiabetic plants) | reported qualitatively | Benefit |
| PMID 24438170 2014 | Meta-analysis | - | - | Fasting glucose | -0.96 mmol/l (95% CI: -1.52, -0.40) | Benefit |
| PMID 24438170 2014 | Meta-analysis | - | - | HbA1c | -0.85% mean change difference (95% CI: -1.49%, -0.22%) | Benefit |
| PMID 24438170 2014 | Meta-analysis | - | - | Postload glucose | -2.19 mmol/l (95% CI: -3.19, -1.19) | Benefit |
| PMID 21843614 2011 | Meta-analysis | - | - | Fasting glucose with Ipomoea batatas | -10.20 mg/dL (95% CI -5.32 mg/dL to -15.08 mg/dL; P<0.0001) | Benefit |
| PMID 21843614 2011 | Meta-analysis | - | - | Fasting glucose with milk thistle | -38.05 mg/dL (95% CI -9.54 mg/dL to -66.57 mg/dL; P = 0.009) | Benefit |
| PMID 21843614 2011 | Meta-analysis | - | - | Glycemic control with cinnamon | reported qualitatively | No benefit |
| PMID 21843614 2011 | Meta-analysis | - | - | HbA(1c) with fenugreek | -1.13% mean difference (95% CI -0.11% to -2.14%; P = 0.03) | Benefit |
| PMID 21843614 2011 | Meta-analysis | - | - | HbA(1c) with Ipomoea batatas | -0.30% mean difference (95% CI -0.04% to -0.57%; P = 0.02) | Benefit |
| PMID 21843614 2011 | Meta-analysis | - | - | HbA(1c) with milk thistle | -1.92% mean difference (95% CI -0.51% to -3.32%; P = 0.008) | Benefit |
| PMID 31583253 2019 | Randomised trial | 57 | one month | High-density lipoprotein cholesterol | 21.7% (P < 0.001) | Benefit |
| PMID 31583253 2019 | Randomised trial | 57 | one month | Low-density lipoprotein cholesterol | 23.4% (P < 0.001) | Benefit |
| PMID 31583253 2019 | Randomised trial | 57 | one month | Total cholesterol | 13.6% (P < 0.001) | Benefit |
| PMID 31583253 2019 | Randomised trial | 57 | one month | Triglyceride | 23.53% (P < 0.05) | Benefit |
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Adjunctive berberine for schizophrenia with metabolic syndrome: a systematic review and meta-analysisXie K, et al. · Frontiers in psychiatry · 2026PMID 42433212 ↗02The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-analysis of Randomized Controlled TrialsNazari A, et al. · Clinical therapeutics · 2024PMID 38016844 ↗03Effect of Fenugreek on Hyperglycemia: A Systematic Review and Meta-AnalysisShabil M, et al. · Medicina (Kaunas, Lithuania) · 2023PMID 36837450 ↗04Effect of saffron and fenugreek on lowering blood glucose: A systematic review with meta-analysisCorreia AGDS, et al. · Phytotherapy research : PTR · 2023PMID 36992660 ↗Be the first to share what you noticed with Fenugreek for blood sugar control. How we calculate this.